Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT04663217 Completed - Clinical trials for Hypertension, Pulmonary

Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension

EXERTION
Start date: November 1, 2020
Phase:
Study type: Observational [Patient Registry]

This study aims to investigate the exercise profile in pulmonary hypertension patients with either pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension or pulmonary hypertension due to left heart disease and in disease control.

NCT ID: NCT04661813 Completed - Hypertension Clinical Trials

Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV

AAIM-High
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Social distancing measures put in place to combat the COVID-19 disease pandemic may increase social isolation and impact cardiovascular disease prevention behaviors among people living with HIV (PLWH). This study builds on a previously developed nurse-led intervention to improve blood pressure and cholesterol care for PLWH. The investigators will adapt the intervention to be administered virtually in order to facilitate cardiovascular prevention care within the US health care system which has sustained long-term changes as a result of the COVID-19 pandemic. The implementation and effectiveness of the intervention will be tested in a 12-month single arm intervention study.

NCT ID: NCT04660370 Completed - Clinical trials for Hypertension and Dyslipidemia

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

CKD-348
Start date: January 9, 2021
Phase: Phase 1
Study type: Interventional

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348

NCT ID: NCT04656847 Completed - Clinical trials for Coronary Artery Disease

PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

PRIDE
Start date: March 1, 2021
Phase:
Study type: Observational

This non-interventional, ambispective study was aimed at evaluating the effectiveness, safety, and tolerability of bisoprolol and perindopril SPC in previous myocardial infarction patients with HTN and CAD treated with the drug for 12 weeks in the daily clinical practice. SPC will be used according to the approved instruction for medical use of the medicine. This is a multi-centre, observational, incomparative, ambispective study, which will retrospectively and prospectively collect clinical variables and socio-demographic data from medical records of patients with HTN and previous MI initiated with bisoprolol/perindopril SPC in real life settings.

NCT ID: NCT04656093 Completed - Hypertension Clinical Trials

Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The goal of the parent R01 study has been to determine how beliefs about chronic illness and their treatments affect SMB in the context of chronic obstructive pulmonary disease (COPD) with comorbid hypertension (HTN) and or diabetes (DM). The educational counseling modules the study team plans to pilot test are rooted in the Self-Regulation Model (SRM), a theory of health behaviors that has been used to develop interventions, but has only been applied to research on behaviors around single diseases.

NCT ID: NCT04649463 Completed - Hypertension Clinical Trials

Ambulatory Blood Pressure Monitoring in Patients With Coronary Artery Disease

PCI-BP
Start date: April 6, 2009
Phase: N/A
Study type: Interventional

Background: Office blood pressure (OBP) is used for diagnosing and treating hypertension but ambulatory blood pressure measurement (ABPM) associates more accurately with patient outcome. The optimal blood pressure in patients with coronary artery disease (CAD) is still unknown. Our objective was to investigate whether physician awareness of ABP after percutaneous coronary intervention (PCI) improved BP-control. Methods: A total of 201 patients performed ABPM before and after their PCI follow-up visit. Patients were randomized to open (O) or concealed (C) ABPM results for the physician at the follow-up visit. The change in ABP and antihypertensive medication in relation to baseline ABP was compared between the two groups.

NCT ID: NCT04645550 Completed - Cirrhosis Clinical Trials

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)

Start date: November 22, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether Apixaban, Warfarin and Aspirin Anticoagulation are effective and safe in Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients after Laparoscopic Splenectomy

NCT ID: NCT04640519 Completed - Stroke Clinical Trials

Telehealth After Stroke Care: Integrated Multidisciplinary Access to Post-stroke Care

TASC
Start date: October 20, 2020
Phase: N/A
Study type: Interventional

The Telehealth After Stroke Care (TASC) trial is a pilot randomized controlled trial. It aims to evaluate the feasibility of a telehealth based model providing multidisciplinary access including nursing, pharmacy and physician care, and obtain preliminary evidence of efficacy of an integrated telehealth approach to blood pressure management after stroke.

NCT ID: NCT04633551 Completed - Pre-Eclampsia Clinical Trials

Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes

VIA
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the past 3 years to receive an anti-inflammatory supplement or serve as a time control. Investigators will compare blood pressure, arterial stiffness, blood vessel reactivity, and blood markers of inflammation between women who did and did not receive the supplement. Investigators will determine women's attitudes about taking a dietary supplement and measure whether the participants who receive the supplement take all or most of the doses.

NCT ID: NCT04633538 Completed - Clinical trials for Pulmonary Hypertension

Evaluation of a New 6 Minute Walk Test Smartphone App in Patients With Pulmonary Hypertension

6-APP
Start date: January 15, 2018
Phase:
Study type: Observational

Comparison of standard 6 minute walk test with 6 minute walk test smartphone app.